Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB)
CUSIP: 207523101
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Ordinary Shares, par value $0.000174 per share
- Shares outstanding
- 62,779,302
- Total 13F shares
- 3,181,027
- Share change
- +236,295
- Total reported value
- $4,372,490
- Price per share
- $1.38
- Number of holders
- 14
- Value change
- +$306,229
- Number of buys
- 6
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 207523101?
CUSIP 207523101 identifies CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 207523101:
Top shareholders of CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BML Capital Management, LLC |
13F
|
Company |
3.3%
|
2,093,232
|
$3,014,045 | — | 30 Sep 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.81%
|
510,701
|
$725,195 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.28%
|
175,500
|
$252,702 | — | 30 Sep 2024 | |
| Callan Capital, LLC |
13F
|
Company |
0.07%
|
41,823
|
$60,221 | — | 30 Sep 2024 | |
| Keudell/Morrison Wealth Management |
13F
|
Company |
0.05%
|
33,450
|
$48,165 | — | 30 Sep 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.05%
|
30,600
|
$44,000 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
27,961
|
$39,704 | — | 30 Sep 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
20,000
|
$29,000 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
9,500
|
$13,489 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
1,838
|
$2,647 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
121
|
$172 | — | 30 Sep 2024 |
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) as of Q4 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.